RNU6-897P

Across TCGA pan-cancer cohorts, RNU6-897P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-897P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-897P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-897P expression acts as an unfavorable survival marker, although some lineages such as LUAD and UCS show a favorable association.

STAD, KIRP, and READ are the cancer types where RNU6-897P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Quartile	IV	0.109	0.745	<.001	112	view →
KIRP	DFS	Tertile	II,III,IV	0.165	0.703	.008	42	view →
READ	DFS	Tertile	III,IV	0.082	0.749	<.001	36	view →
LUAD	DFS	Tertile	All	1.000	0.650	.001	36	view →
SKCM	DFS	Tertile	II,III,IV	0.370	0.576	.005	30	view →
BLCA	DFS	Tertile	IV	0.269	0.484	.019	18	view →
UCS	OS	Tertile	IV	1.000	0.293	.035	18	view →
ACC	DFS	Tertile	III,IV	0.048	0.457	.015	18	view →
ESCA	DFS	Tertile	IV	0.221	0.539	.046	12	view →
TGCT	DFS	Tertile	All	0.953	0.766	.041	12	view →
PAAD	OS	Tertile	II,III,IV	0.346	0.571	.021	9	view →
THCA	DFS	Tertile	All	1.000	0.822	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-897P–STAD (DFS)

Open the STAD breakdown →